Compositions comprising mixtures of compounds and uses thereof

A composition comprising:

• (a) niacin, or a pharmaceutically acceptable salt thereof;
• (b) berberine, or a pharmaceutically acceptable salt thereof;
• (c) silymarin, silibinin, or Siliphos® (formulated silibinin), or any combination thereof, or a pharmaceutically acceptable salt thereof;
• (d) lipoic acid, or a pharmaceutically acceptable salt thereof;
• (e) taurine, or a pharmaceutically acceptable salt thereof;
• and
• (f) phospholipid or a pharmaceutically acceptable salt thereof;
• wherein the silymarin, silibinin, Siliphos® (formulated silibinin), any combination thereof, or pharmaceutically acceptable salt thereof, is complexed with the phospholipid;
• wherein the niacin, or the pharmaceutically acceptable salt thereof, is in an amount from about 20% to about 40% by weight;
• wherein the berberine, or the pharmaceutically acceptable salt thereof, is in an amount from about 10% to about 20% by weight;
• wherein the silymarin, or the pharmaceutically acceptable salt thereof, the silibinin, or the pharmaceutically acceptable salt thereof, and/or the Siliphos® (formulated silibinin), or the pharmaceutically acceptable salt thereof, combined, are in an amount from about 8% to about 20% by weight;
• wherein the lipoic acid, or the pharmaceutically acceptable salt thereof, is in an amount from about 5% to about 15% by weight;
• wherein the taurine, or the pharmaceutically acceptable salt thereof, is in an amount from about 20% to about 35% by weight;
• and
• wherein the phospholipid, or the pharmaceutically acceptable salt thereof, is in an amount selected from about 5% to about 20% by weight.